Clinical Trial Update: Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating azacitidine in combination with homoharringtonine-based regimens for acute myeloid leukemia is reported as ongoing with status unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Homoharringtonine-based regimens (homoharringtonine-based regimens)

Snippet

Sponsor: Ge Zheng | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN